Law360, New York (October 19, 2009) -- The U.S. Court of Appeals for the Second Circuit has overturned a lower court's dismissal of an antitrust case alleging that Ferring Pharmaceuticals Inc. and Aventis Pharmaceuticals Inc. conspired to keep generic drugs off the shelves by fraudulently acquiring a patent for diabetes drug DDAVP.
The Second Circuit on Friday vacated and remanded a ruling handed down by the late Judge Charles Brieant of the U.S. District Court for the Southern District of New York...
